The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis
- PMID: 38445713
- PMCID: PMC11308168
- DOI: 10.1093/jnci/djae056
The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis
Abstract
Background: Triple-negative breast cancer (TNBC) has a poor prognosis compared with other breast cancer subtypes. This systematic review and meta-analysis examines whether known risk factors for breast cancer are also associated with TNBC in adult women.
Methods: EMBASE, Medline, SCOPUS, and gray literature were queried with no limit on the date or language of publication. The exposures of interest included parity, breastfeeding, duration of breastfeeding, age at menarche, age at first live birth, oral contraceptive (OC) use, duration of OC use, use of menopausal hormone therapy (MHT), family history, body mass index (BMI), alcohol use, smoking, and breast density. The main outcome of interest was TNBC. Study quality was determined using the Newcastle-Ottawa scale for case control studies and cohort studies. We estimated weighted odds ratios from random effects models to study the exposure-outcome associations. Protocol was registered under the number: PROSPERO 2021 CRD42021254594.
Results: Thirty-three studies were included. Family history, longer duration of OC use, and higher breast density were significantly associated with increased risk for TNBC, whereas later age at menarche, later age at first birth, and breastfeeding were protective against TNBC. Parity, MHT, alcohol, smoking, and BMI were not significantly associated with TNBC overall, but higher parity was associated with higher risk among Black women.
Conclusion: Our findings highlight that TNBC has a distinct risk factor profile compared with overall breast cancer. This can be the foundational work in identification of actionable TNBC risk factors to improve prevention and early detection of these poor prognosis breast tumors.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
The authors report no conflicting interests associated with this work.
Figures
Similar articles
-
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.BMC Cancer. 2023 Jul 10;23(1):644. doi: 10.1186/s12885-023-11049-0. BMC Cancer. 2023. PMID: 37430191 Free PMC article.
-
Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study.Sci Rep. 2023 Aug 20;13(1):13551. doi: 10.1038/s41598-023-40443-8. Sci Rep. 2023. PMID: 37599285 Free PMC article.
-
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.Breast Cancer Res. 2017 Jan 13;19(1):6. doi: 10.1186/s13058-016-0799-9. Breast Cancer Res. 2017. PMID: 28086982 Free PMC article.
-
Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.Hum Reprod Update. 2016 Dec;23(1):126-138. doi: 10.1093/humupd/dmw037. Epub 2016 Sep 21. Hum Reprod Update. 2016. PMID: 27655589 Review.
-
Reproductive risk factors and breast cancer subtypes: a review of the literature.Breast Cancer Res Treat. 2014 Feb;144(1):1-10. doi: 10.1007/s10549-014-2852-7. Epub 2014 Jan 30. Breast Cancer Res Treat. 2014. PMID: 24477977 Free PMC article. Review.
Cited by
-
Parallel Battles: Managing Synchronous Cervical and Triple-Negative Breast Cancers.Cureus. 2024 Sep 25;16(9):e70201. doi: 10.7759/cureus.70201. eCollection 2024 Sep. Cureus. 2024. PMID: 39463536 Free PMC article.
-
Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer.Cancers (Basel). 2024 Jul 15;16(14):2544. doi: 10.3390/cancers16142544. Cancers (Basel). 2024. PMID: 39061185 Free PMC article.
References
-
- Rakha EA, Elsheikh SE, Aleskandarany MA, et al.Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 2009;15(7):2302-2310. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources